Prostate-specific antigen-based prostate cancer screening: Past and future.
作者： Arnout R Alberts , Ivo G Schoots , Monique J Roobol
DOI: 10.1111/IJU.12750
关键词:
摘要: Prostate-specific antigen-based prostate cancer screening remains a controversial topic. Up to now, there is worldwide consensus on the statement that harms of population-based screening, mainly as result overdiagnosis (the detection clinically insignificant tumors would have never caused any symptoms), outweigh benefits. However, opportunistic takes place wide scale. The European Randomized Study Screening for Prostate Cancer showed reduction in mortality through prostate-specific antigen based-screening. These data need be individualized order avoid those who cannot benefit and start will. For lacking more optimal approach, should only started after process shared decision-making. focus future research unnecessary testing by further better biomarkers value multiparametric magnetic resonance imaging, potentially combined already existing multivariate risk prediction models.
sci-hub.se 参考文章(118)
, , Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010 International Journal of Urology. ,vol. 17, pp. 830- 838 ,(2010) , 10.1111/J.1442-2042.2010.02613.X
Samuel K. Stephenson, Edward K. Chang, Leonard S. Marks, Screening and Detection Advances in Magnetic Resonance Image–Guided Prostate Biopsy Urologic Clinics of North America. ,vol. 41, pp. 315- 326 ,(2014) , 10.1016/J.UCL.2014.01.007
Declan G. Murphy, Thomas Ahlering, William J. Catalona, Helen Crowe, Jane Crowe, Noel Clarke, Matthew Cooperberg, David Gillatt, Martin Gleave, Stacy Loeb, Monique Roobol, Oliver Sartor, Tom Pickles, Addie Wootten, Patrick C. Walsh, Anthony J. Costello, The Melbourne Consensus Statement on the early detection of prostate cancer BJUI. ,vol. 113, pp. 186- 188 ,(2014) , 10.1111/BJU.12556
Bob Djavan, Mesut Remzi, Claude C Schulman, Michael Marberger, Alexandre R Zlotta, Repeat Prostate Biopsy: Who, How and When?: A Review European Urology. ,vol. 42, pp. 93- 103 ,(2002) , 10.1016/S0302-2838(02)00256-7
Kathryn K. Hodge, John E. McNeal, Martha K. Terris, Thomas A. Stamey, Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate The Journal of Urology. ,vol. 142, pp. 71- 74 ,(1989) , 10.1016/S0022-5347(17)38664-0
Jérémie Haffner, Laurent Lemaitre, Philippe Puech, Georges‐Pascal Haber, Xavier Leroy, J Stephen Jones, Arnauld Villers, None, Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection. BJUI. ,vol. 108, ,(2011) , 10.1111/J.1464-410X.2011.10112.X
Anders christensson, Thomas Björk, Olle Nilsson, Ulrika Dahlén, Marja-Terttu Matikainen, Abraham T.K. Cockett, Per-Anders Abrahamsson, Hans Lilja, Serum Prostate Specific Antigen Complexed to α1-Antichymotrypsin as an Indicator of Prostate Cancer The Journal of Urology. ,vol. 150, pp. 100- 105 ,(1993) , 10.1016/S0022-5347(17)35408-3
Stephen D. Mikolajczyk, Harry G. Rittenhouse, Lisa S. Millar, Kevin M. Slawin, Thomas M. Wheeler, Weitao Song, Tang J. Wang, Leonard S. Marks, A Precursor Form of Prostate-specific Antigen Is More Highly Elevated in Prostate Cancer Compared with Benign Transition Zone Prostate Tissue Cancer Research. ,vol. 60, pp. 756- 759 ,(2000)
Tiago M. de Carvalho, Eveline A.M. Heijnsdijk, Harry J. de Koning, Screening for prostate cancer in the US? Reduce the harms and keep the benefit. International Journal of Cancer. ,vol. 136, pp. 1600- 1607 ,(2015) , 10.1002/IJC.29136
Heidi A. van Vugt, Monique J. Roobol, Martijn Busstra, Paul Kil, Eric H. Oomens, Igle J. de Jong, Chris H. Bangma, Ewout W. Steyerberg, Ida Korfage, Compliance with biopsy recommendations of a prostate cancer risk calculator BJUI. ,vol. 109, pp. 1480- 1488 ,(2012) , 10.1111/J.1464-410X.2011.10611.X